Aspen Pharmacare

Tweet this page
Registration as it was on 28 Feb 2023
How to read and use this data card.
Download this datacard


WARNING: As this organisation lists one or more EP accredited lobbyists, it may not be probable that its lobbying costs are lower than €10,000.

Lobbying Costs

10,000€ - 24,999€

Financial year: Jul 2021 - Jun 2022

Lobbyists (Full time equivalent)

0.1 Fte (1)

Lobbyists with EP accreditation


High-level Commission meetings


Lobbying Costs over the years

  • Info

    Aspen Pharmacare   (ASP)

    EU Transparency Register

    204680631588-97 First registered on 22 May 2018

    Goals / Remit

    Aspen Pharmacare is a South-African pharmaceutical company.
    Aspen operates with an established business presence in approximately 50 countries and supply products in more than 150 countries. We have a proud heritage dating back more than 160 years and are committed to sustaining life and promoting healthcare through increasing access to our high quality, affordable medicines and products.

    We are a leading global player in specialty and branded pharmaceuticals with an extensive basket of products that provide treatment for a broad spectrum of acute and chronic conditions experienced through all stages of life. We continue to benefit the lives of patients using our products in more than 150 countries.

    Aspen has identified Anaesthetics, High Potency & Cytotoxics, Antthrombotics and Nutritionals as our focused therapeutic categories that will receive our highest focus based on materiality and future potential.

    We operate 25 manufacturing facilities across 17 sites.

    Main EU files targeted

    Aspen currently follows European policies, legislative files related to our Pharmaceuticals and any EU project(mainly in Anesthetesia and Oncology). We are particularly interested in European initiatives to support medicine affordability to patients and any initiatives to support production investment in the European countries.
    Our domains of interest includes also Data Protection Regulation, Brexit consequences, Pharmaceutical Industry strategy, and EU pricing & trade Policy.


    Head Office
    Aspen Place 9 Rydall Vale Park Douglas Saunders Drive, La Lucia Ridge
    Durban Gateway, 4321 - P O Box 25125
    EU Office
    Montgelasstrasse 14
    München 81679


  • People

    Total lobbyists declared


    Employment timeLobbyists

    Lobbyists (Full time equivalent)


    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 02 Oct 2023

    Name Start date End Date
    Mr Fabrice JOVER 29 May 2018 29 May 2019

    Complementary Information

    Current Position: Market Access & Tender Management Lead; overviewing EU Pharma Activities like Revision of EU general pharmaceutical legislation; EU Proposed directive on corporate sustainability due diligence, Relevance of the Green Deal,

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories


    Companies & groups

  • Networking


    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jul 2021 - Jun 2022

    Lobbying costs for closed financial year

    10,000€ - 24,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    10,000€ - 24,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)


    Groups (European Parliament)


    Other activities

    Aspen is dedicated to work with EU Authorities and to build sustainable partnership with the EU countries. Aspen has an strong supply presence in France at Notre-Dame de Bondeville, in Germany at Bad Odesloe and in Netherlands at Oss. Commercial presence in all EU countries.

  • Meetings


    None declared

Download this datacard